Austin Heart, a provider of cardiac and vascular services, has started enrolling peripheral arterial disease (PAD) patients for Avinger's Connect II trial. The multi-center, non-randomized and prospective trial is designed to evaluate ...
Tags: Austin Heart, PAD patients, Connect II trial, peripheral arterial disease
Avinger has completed enrolling peripheral artery disease (PAD) patients in its CONNECT II clinical trial. The prospective, multi-center, non-randomized trial that evaluated 100 PAD patients with femoropopliteal CTO lesions was ...
Tags: clinical trial, peripheral artery disease, clinical technology, Avinger